Andrea Giovanni Migliavacca
Think4Future Srl, Milan, Italy
Title: AMONTRACk- mHealth app to support Parkinson's patients to be more engaged
Biography
Biography: Andrea Giovanni Migliavacca
Abstract
AMONTRACk, project co-funded by the Lombardy, saw the collaboration between Think4Future and the Casa di Cura del Policlinico to test LifeCharger, an app to support the chronic patient in the management of his/her therapies. Parkinson's disease is a chronic neurodegenerative disease with an evolutionary character that is characterized by the presence of bradykinesia, tremor, rigidity and other motor and non-motor symptoms. The onset of Parkinson's disease is usually asymmetric and has an excellent response to dopaminergic drug therapy. From the early stages of the disease, close monitoring of the patient's proper drug intake is necessary to avoid the occurrence of motor blocking or dyskinesias. Over time the therapy must be personalized continuously based on the characteristics of the patient, the stage of illness and the functional request of the same. This condition, among the chronic diseases, is particularly suitable for testing LifeCharger, as an instrument able to monitor not only the right therapy but also the presence of pathognomonic signs and symptoms of the disease and its development, supporting the clinician in his therapeutic choices with specifi c and useful reports. Thanks to this monitoring, also factors related to the autonomy of everyday life can be corrected where necessary, aiming for a better quality of life and optimization of the therapeutic response. For chronic Parkinson's patients, there is a close correlation between the correct intake of therapies and the occurrence of symptoms. Allowing the patient to record these events with precision, also with the support of the caregiver, the treating physicians can modulate more precisely the therapies or the possible temporal scan of the same.